Nortriptyline Hydrochloride

DRUG3 trials

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Washington, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions

Chronic Kidney DiseaseIdiopathic GastroparesisSmall Cell Carcinoma

Phase 1

Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma

CompletedNCT02881125

University of WashingtonSmall Cell Carcinoma

Start: 2016-11-03End: 2019-11-30Updated: 2019-12-17

Phase 3

Nortriptyline for Idiopathic Gastroparesis

CompletedNCT00765895

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Idiopathic Gastroparesis

Start: 2009-01-31End: 2012-10-31Updated: 2020-05-14

Unknown Phase

Nortriptyline and the Risk of Serious Adverse Events

Active, not recruitingNCT07527481

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sChronic Kidney Disease

Start: 2008-01-01End: 2027-12-31Updated: 2026-09-14

Related Papers

Effect of Nortriptyline on Symptoms of Idiopathic Gastroparesis

JAMA2013-12-24172 citations